News & insights
Clean the data once, use it many times: an AIDAVA retrospective
Maastricht, The Netherlands, August 2026 – The EU-funded AIDAVA project has published the results of four years of work on a problem that stands between Europe and its new health data rules: messy clinical data must repeatedly be turned into interoperable, reusable, high-quality data. From March 2029, per the European Health Data Space (EHDS) regulation, hospitals across the EU will progressively face new obligations to make defined categories of electronic health data available for cross-border primary use and respond to research requests coordinated through national Health Data Access Bodies. Hospitals already perform multiple mandatory reporting and data-submission processes today. These… Continue reading Clean the data once, use it many times: an AIDAVA retrospective
Read articleSeeking patients diagnosed with rare or autoimmune diseases!
Living with a rare or autoimmune disease? A simple blood sample can support Biobank.ro research. Biobank.ro is Romania’s first private biobank, built on a federated data network and a privacy-by-design architecture, with a primary focus on rare and autoimmune diseases. Established by Egnosis and Pro-Vitam, it is designed to support secure, collaborative, and high-impact biomedical research. While we are designing the new biobank headquarters, research activities are already underway. At this stage, we are seeking patients diagnosed with rare or autoimmune diseases who are willing to contribute a small blood sample and associated medical data. The goal is to develop… Continue reading Seeking patients diagnosed with rare or autoimmune diseases!
Read articleREPO4EU platform development update
We are approximately 1.5 years from project completion and six months from a mid-milestone – key points for presenting new versions of the @REPO4EU Platform. At full steam ahead, we are now developing the platform’s interim Beta version, scheduled for launch in Berlin this September. For this, participation in the SC Meeting last week in Brussels was critical and timely. During this meeting, alongside the project coordinator and work package leaders, we reviewed specific task results within the project scope. These research outcomes are highly important as they are integral to the comprehensive platform’s development. The base is taking shape,… Continue reading REPO4EU Platform Development Update
Read articleComunicat de implementare proiect Biobank.ro
Titlul proiectului: Biobank.ro – centru de date și de probe biologice pentru cercetare medicală asistată de inteligența artificialăCod SMIS: 339613Scopul proiectului: Dezvoltarea capacității de CDI a Egnosis SRL. prin adoptarea tehnologiilor avansateși dezvoltarea de competente pentru specializare inteligentă.Beneficiar: Egnosis SRL și Pro-Vitam SRLPerioada de implementare: 30.09.2025 – 29.09.2028 Valoarea totală a proiectului (Lei): 14.651. 039,89 LeiValoarea cofinanțării UE (lei): 8.078.5 73,06 Lei Obiectivul general al proiectului îl constituie dezvoltare a capacității de CDI a Egnosis S.R.L. prin doptarea tehnologiilor avansate și dezvoltarea de competențe pentru specializare inteligentă. Acesta contribuie la atingerea obiectivului de politică al PR Centru 2021–2027, „O regiune… Continue reading Comunicat de implementare proiect Biobank.ro
Read articleBiobank.ro – first of its kind in Eastern Europe
Biobank.ro is founded on a strong basis of scientific and technological excellence, heralding a new era in Romania’s biomedical research infrastructure. Formed through a strategic partnership between Egnosis (the project lead) and Pro-Vitam (the project partner), this initiative will establish Romania’s first private biobank built on a federated database network and a privacy-by-design architecture, enabling fast and collaborative research with a primary focus on rare and autoimmune diseases. Created primarily for research purposes, Biobank.ro integrates a digital data hub with a biological sample center to advance AI-driven medical research and strengthen Romania’s role in international scientific collaboration. The concept … Continue reading Biobank.ro – first of its kind in Eastern Europe
Read articleThe power of research and development for SMEs
On September 19, 2025, the first ECONMATH Conference brought together academics, entrepreneurs, innovation leaders and students to explore the intersection of economics, mathematics, and research-driven business strategies. Representing Egnosis, Dr. Mónika Moga, PhD, shared insights on how Romanian small and medium-sized enterprises (SMEs) can effectively leverage research and development (R&D) results to accelerate growth and remain competitive in an evolving digital landscape. Her presentation, “Innovation in-house: How can SMEs make use of R&D results”, highlighted both statistical evidence and practical lessons from our company’s two decades of experience in data-driven IT solutions. An empirical perspective: R&D in Romania and beyond… Continue reading The power of research and development for SMEs
Read articleEgnosis supporting dAIbetes at Harvard University in Boston
We have recently concluded the steering committee meeting of the dAIbetes_HorizonEurope project, an exceptional meeting that took place at the Biological Labs of Harvard University in Boston. Over two days of productive meetings with project partners, we assessed the progress made over the past 18 months of research and multidisciplinary collaboration. We’ve reaffirmed that virtual patient twins represent a transformative step in healthcare, improving prediction accuracy by at least 10% over standard models and enabling personalized care for diabetes and other diseases. Large language models (LLMs) accelerate and streamline research across areas such as data preprocessing and subsequent validation studies…. Continue reading Egnosis supporting dAIbetes at Harvard University in Boston
Read articleNew ambitions by attending RoHealth Cluster
The new year has brought us a new milestone in our efforts to enhance research and development in healthcare by attending the RoHealth community, the leading health and bioeconomy organization in Romania, providing us with access to a vast network of stakeholders in Romania’s healthcare sector. About RoHealth Cluster This professional organization focuses on creating and implementing initiatives and activities that enhance the fields of health and bioeconomy. The goal of the cluster is to foster competitiveness and innovation, promoting collaboration among companies, organizations, universities, and public entities. This diverse community that links 100+ members contributes their expertise to transform… Continue reading New ambitions by attending RoHealth Cluster
Read articleR&D shines in the spotlight in Budapest
Last week, we attended prestigious scientific, R&D-oriented events in Budapest. The 32nd Semmelweis Symposium focused on network medicine for future healthcare, mapping the most outstanding research results and breakthroughs in network sciences, systems biology and human dynamics. The multi-faceted approach to bioinformatics research pointed back to the EU summit in Budapest in early November, where R&D was given increased attention. The symposium was also an excellent opportunity to organize a face-to-face meeting within the REPO4EU project, resulting in crucial decisions. Let’s see what these meetings were all about. 32nd Semmelweis Symposium Thought-provoking presentations used different approaches to examine the human… Continue reading R&D shines in the spotlight in Budapest
Read articleREPO4EU and REMEDi4ALL met in Bruxelles
Last week, on October 30, Egnosis participated in the Drug Repurposing Cluster meeting in Brussels hosted by the European Health and Digital Executive Agency (HaDEA). This gathering served as a valuable touchpoint for Horizon Europe-funded projects REPO4EU and REMEDi4ALL, providing opportunities to showcase recent advancements and foster collaboration. EU project officer Monica Ensini commenced the tight agenda. In her warm, welcoming address, she outlined the significance and priority of the two named projects, as the expectations placed upon them are extremely high. Further, the coordinators—Harald H.H.W. Schmidt from REPO4EU, Anton Ussi and Donald Lo from REMEDi4ALL—presented the projects’ results so… Continue reading REPO4EU and REMEDi4ALL met in Bruxelles
Read articleRExPO24 in Munich
Munich has not only been whizzing about the EURO2024 championship but also systems medicine, as last week hosted RExPO24, the 3rd International Conference on Systems Medicine, AI & Drug Repurposing, uniting experts and participants to form a robust drug-repurposing community. The Egnosis delegation was also present at the event. Besides, our colleague Balázs Orbán delivered a captivating presentation on the potential of precision drug repurposing through the RePo4EU unified platform. The RePo4EU unified platform Within REPO4EU, the Horizon Europe-funded research project, we aim to establish a first-in-class coherent and innovative web-based platform for safe and efficient drug repurposing for all… Continue reading RExPO24 in Munich
Read articleNew project kickoff: dAIbetes
In a significant stride towards advancing precision medicine, a consortium coordinated by Prof. Dr. Jan Baumbach from the University of Hamburg (Germany), with 13 partners from seven countries, including Egnosis, has been awarded a prestigious Horizon Europe grant to develop a cutting-edge federated health data infrastructure. The project named “dAIbetes” is revolutionizing Type 2 diabetes care. It focuses on leveraging virtual twins as predictive tools in personalized disease management, targeting treatment outcomes in type2 diabetes. The project started on 01 January 2024. To develop virtual twins as prognostic tools for precision medicine the partners of dAIbetes will integrate extensive datasets… Continue reading New project kickoff: dAIbetes
Read articleMicrob-AI-ome project kicks off!
In April, the Horizon Europe project Microb-AI-ome kicks off in Hamburg, Germany. The event was hosted by the project’s coordinator Prof. Dr. Jan Baumbach, from the University of Hamburg. Egnosis, as one of eight partner organizations, also attended the meeting. The Microb-AI-ome consortium combines expertise in CRC and its treatment, microbiomics, artificial intelligence, software development, and privacy protection to close the gap between privacy and big data in international medical research. What is Microb-AI-ome’s goal? Colorectal cancer (CRC) is the 2nd most common type of cancer in the world (WHO Global Health Estimates 2019). However, identifying CRC early improves disease… Continue reading Microb-AI-ome project kicks off!
Read article